{
  "abstract": "Background\n\nHuman papillomavirus includes more than 200 types, classified by cancer risk. Since 2006, the vaccine has effectively prevented human papillomavirus infection and associated cancers; however, coverage among adults remains low. Furthermore, research examining human papillomavirus vaccination among adults with a cancer history is limited.Objective\n\nTo estimate vaccination uptake for human papillomavirus among U.S. adults aged 20-47 and compare uptake by cancer history.Methods\n\nThis study used data from the National Health and Nutrition Examination Survey from 2011 to 2023. The final analytic sample included 13,511 adults aged 20-47 with self-reported vaccination status and cancer history. The data were weighted to account for the complex survey design and produce nationally representative estimates.Results\n\nAmong eligible adults, 84.7% were unvaccinated, 2.9% were under-vaccinated, and 12.4% had completed the vaccine series. Among eligible adults with a self-reported cancer history, the majority were unvaccinated. Vaccination completion differed by sociodemographic and healthcare-related factors.Conclusions\n\nHuman papillomavirus vaccination remained low among eligible U.S. adults, including those with a self-reported cancer history. These findings support efforts to improve adult vaccination coverage and prevent human papillomavirus infections and associated cancers.",
  "abstract_shown": true,
  "affiliations": [
    "College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health, Florida A&M University, Tallahassee, FL 32307, USA."
  ],
  "article_type": "research article",
  "arxiv": null,
  "author_total": 2,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Jessica Saintibert",
      "orcid": "0009-0001-7568-9215"
    },
    {
      "affs": [
        0
      ],
      "name": "Tammie M Johnson",
      "orcid": "0000-0003-1857-1111"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/7gz227qzxf1rp.bib",
  "cited_by": 0,
  "doi": "10.3390/vaccines14100892",
  "fulltext_url": "https://europepmc.org/articles/PMC13709472",
  "id": "7gz227qzxf1rp",
  "issns": [
    "2076-393X"
  ],
  "landing_url": "https://europepmc.org/article/MED/42931421",
  "language": "eng",
  "licence": "CC-BY",
  "licence_label": "CC BY",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "openalex",
      "2713|Cervical Cancer and HPV Research"
    ]
  ],
  "openalex": "W7221520953",
  "pdf_url": "https://europepmc.org/articles/PMC13709472?pdf=render",
  "pmcid": "PMC13709472",
  "pmid": "42931421",
  "published": "2026-10-12",
  "publisher": null,
  "ris": "https://research.draconitic.com/paper/7gz227qzxf1rp.ris",
  "sources": [
    {
      "first_seen": "2026-10-30T12:22:01Z",
      "native_id": "MED:42931421",
      "source": "europepmc",
      "url": "https://europepmc.org/article/MED/42931421"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2713|Cervical Cancer and HPV Research",
      "subfield": "epidemiology-public-health"
    }
  ],
  "title": "HPV Vaccination Uptake Among Vaccine-Eligible U.S. Adults with and Without a Cancer History: A National Health and Nutrition Examination Survey Analysis, 2011-2023.",
  "title_text": "HPV Vaccination Uptake Among Vaccine-Eligible U.S. Adults with and Without a Cancer History: A National Health and Nutrition Examination Survey Analysis, 2011-2023.",
  "type": "peer-reviewed",
  "updated_at": "2026-10-30T12:22:01Z",
  "url": "https://research.draconitic.com/paper/7gz227qzxf1rp",
  "venue": "Vaccines",
  "versions": []
}